HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Progestin drives breast cancer growth by inducing p21(CIP1) expression through the assembly of a transcriptional complex among Stat3, progesterone receptor and ErbB-2.

Abstract
Cell cycle regulator p21(CIP1) has controversial biological effects in breast cancer since in spite of its role as cell cycle inhibitor and promoter of cellular senescence, it also induces cell proliferation and chemoteraphy resistance. We here explored the molecular mechanisms involved in progestin regulation of p21(CIP1) expression. We also investigated the biological effects of p21(CIP1) in breast cancer cells. We found that the synthetic progestin medroxyprogesterone acetate (MPA) upregulates p21(CIP1) protein expression via c-Src, signal transducer and activator of transcription 3 (Stat3) and ErbB-2 phosphorylation. Notably, we also found that ErbB-2 nuclear function plays a key role in MPA-induction of p21(CIP1) expression. Interestingly, we determined that progestin drives p21(CIP1) transcriptional activation via a novel nonclassical transcriptional mechanism in which progesterone receptor is recruited along with Stat3 and ErbB-2 to a Stat3 binding site at p21(CIP1) promoter. Our findings revealed that ErbB-2 functions as a coactivator of Stat3 in progestin induction of p21(CIP1) transcriptional activation. Furthermore, we demonstrated that blockage of p21(CIP1) expression strongly inhibited in vitro and in vivo progestin-induced breast cancer cell proliferation. These results further support the hypothesis that according to cell context and type of stimulus, p21(CIP1) is capable of inducing cell cycle progression. Moreover, we provided evidence that Stat3 and nuclear ErbB-2 are key players in progestin-induced p21(CIP1) regulation.
AuthorsMaría C Diaz Flaqué, Rocío Vicario, Cecilia J Proietti, Franco Izzo, Roxana Schillaci, Patricia V Elizalde
JournalSteroids (Steroids) Vol. 78 Issue 6 Pg. 559-67 (Jun 2013) ISSN: 1878-5867 [Electronic] United States
PMID23178160 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier Inc. All rights reserved.
Chemical References
  • Cyclin-Dependent Kinase Inhibitor p21
  • Progestins
  • Receptors, Progesterone
  • STAT3 Transcription Factor
  • Stat3 protein, mouse
  • Receptor, ErbB-2
Topics
  • Animals
  • Breast Neoplasms (genetics, metabolism, pathology)
  • Cyclin-Dependent Kinase Inhibitor p21 (biosynthesis, genetics)
  • Female
  • Mice
  • Mice, Inbred BALB C
  • Progestins (pharmacology)
  • Receptor, ErbB-2 (metabolism)
  • Receptors, Progesterone (metabolism)
  • STAT3 Transcription Factor (metabolism)
  • Transcription, Genetic (drug effects, genetics)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: